Lv1
38 积分 2023-10-16 加入
Oral Muvalaplin for Lowering of Lipoprotein(a)
6天前
已完结
Drug discovery targeting Nav1.8: Structural insights and therapeutic potential
13天前
已完结
A structural basis for amylin receptor phenotype
14天前
已完结
Design, Structure–Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-b]pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors
2个月前
已完结
Discovery and In Vivo Exploration of 1,3,4-Oxadiazole and α-Fluoroacrylate Containing IL-17 Inhibitors
2个月前
已完结
Design, Synthesis, and Pharmacological Evaluation of Spiro[carbazole-3,3′-pyrrolidine] Derivatives as cGAS Inhibitors for Treatment of Acute Lung Injury
2个月前
已完结
AZD0780, the first oral small molecule PCSK9 inhibitor for the treatment of hypercholesterolemia: Results from a randomized, single-blind, placebo-controlled phase 1 trial
2个月前
已完结
Discovery and Preclinical Profile of ALG-055009, a Potent and Selective Thyroid Hormone Receptor Beta (THR-β) Agonist for the Treatment of MASH
2个月前
已完结
Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
2个月前
已完结
Anticancer benzoxaboroles block pre-mRNA processing by directly inhibiting CPSF3
3个月前
已完结
皖公网安备34019202002308
